9 results
83 |
Advantage of achieving deep response following frontline daratumumab-VTd compared to VRd in transplant-eligible multiple myeloma: multicenter study
Ja Min Byun, Sung-Soo Park, Sung-Soo Yoon, Ari Ahn, Myungshin Kim, Jung Yeon Lee, Young-Woo Jeon, Seung-Hwan Shin, Seung-Ah Yahng, Youngil Koh, Chang-Ki Min
KMSID: 1516083035 Blood Res. 2023;58(2):83-90. Published online 2023 April 7 DOI: http://dx.doi.org/10.5045/br.2023.2023005 | |
91 |
Efficacy of plasmapheresis in neutropenic patients suffering from cytokine storm because of severe COVID-19 infection
Alireza Sadeghi, Somayeh Sadeghi, Mohammad Saleh Peikar, Maryam Yazdi, Mehran Sharifi, Safie Ghafel, Farzin Khorvash, Behrooz Ataei, Mohammad Reza Safavi, Elahe Nasri
KMSID: 1516083037 Blood Res. 2023;58(2):91-98. Published online 2023 May 10 DOI: http://dx.doi.org/10.5045/br.2023.2022201 | |
99 |
A survey evaluating hematology physicians’ perspectives on central nervous system prophylaxis
Ufuk Demirci, Meltem Kurt Yüksel, Hakkı Onur Kırkızlar, Elif Birtaş Ateşoğlu, Özgür Mehtap, Ozan Salim, Ahmet Muzaffer Demir, Olga Meltem Akay
KMSID: 1516083036 Blood Res. 2023;58(2):99-104. Published online 2023 June 8 DOI: http://dx.doi.org/10.5045/br.2023.2023066 | |
105 |
Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation
Sena Kim, Sora Lim, Farnaz Razmkhah, Jaebok Choi
KMSID: 1516083034 Blood Res. 2023;58(2):105-111. Published online 2023 April 7 DOI: http://dx.doi.org/10.5045/br.2023.2022238 | |
112 |
End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL-may be the way forward
Pritish Chandra Patra, Sujay Rainchwar, Reema Singh, Rohan Halder, Pallavi Mehta, Megha Verma, Rayaz Ahmed, Jyoti Shankar Raichaudhuri, Dinesh Bhurani, Narendra Agrawal, Suman Pramanik
KMSID: 1516083029 Blood Res. 2023;58(2):112-115. Published online 2023 May 10 DOI: http://dx.doi.org/10.5045/br.2023.2022241 | |
116 |
A case report of thrombotic thrombocytopenic purpura-like syndrome after Coronavirus disease 2019 vaccination
Sua Noh, Sang A Kim, Ji Yun Lee, Jeong Ok Lee, Soo Mee Bang
KMSID: 1516083033 Blood Res. 2023;58(2):116-117. Published online 2023 June 14 DOI: http://dx.doi.org/10.5045/br.2023.2023036 | |
118 |
Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report
Sabrine Mekni, Rimmel Yosra Kanoun, Saloua Ladeb, Dorra Belloumi, Nour Ben Abdeljelil, Tarek Ben Othman
KMSID: 1516083032 Blood Res. 2023;58(2):118-120. Published online 2023 June 14 DOI: http://dx.doi.org/10.5045/br.2023.2023061 | |
120 |
An alternative approach to confirm mixed lineage involvement in acute leukemia with KMT2A rearrangement– an illustrative report
Debadrita Ray, Sreejesh Sreedharanunni, Anand Balakrishnan, Praveen Sharma, Nabhajit Mallik, Srinivasan Peyam, Man Updesh Singh Sachdeva
KMSID: 1516083030 Blood Res. 2023;58(2):120-123. Published online 2023 June 30 DOI: http://dx.doi.org/10.5045/br.2023.2023084 | |
124 |
Erratum
KMSID: 1516083031 Blood Res. 2023;58(2):124-124. Published online 2023 June 30 DOI: http://dx.doi.org/10.5045/br.2023.2022218e1 | |